Cr. Pelletier et al., USE OF TEMPORALIS FASCIA FOR EXPOSED HYDROXYAPATITE ORBITAL IMPLANTS, Ophthalmic plastic and reconstructive surgery, 14(3), 1998, pp. 198-203
The hydroxyapatite implant (Bio-Eye, Intergrated Orbital Implant, Inc.
, San Diego, CA, U.S.A.) has gained increasing popularity as an orbita
l implant in recent years. Several complications may occur, including
infection, exposure, extrusion, and various peg problems. Exposure of
the implant appears to be the most common complication, ranging up to
21.6%. Many techniques, including nonsurgical and surgical approaches,
have been described to manage these exposures. When surgery is indica
ted, a patch graft may be required to cover the defect. We report our
experience and technique with autogenous temporalis fascia as a patch
graft. Autografts such as temporalis fascia are easily obtained, bring
about no immunological reaction, and have no risk of infectious trans
mission.